Bond.az White LogoBond.az Black Logo

Ser Educacional Q1 2026 Beats EPS, Misses Revenue

Ser Educacional Q1 2026 beats EPS expectations but misses revenue targets. Stock falls 1.34% after-hours.

Aria Wright
ByAria Wright- Senior Editor
|
0

Ser Educacional S.A. reported mixed Q1 2026 results. Earnings per share (EPS) beat expectations at $0.5355 vs. $0.5109 forecast (4.82% surprise). However, revenue missed at $583.9 million vs. $591.91 million expected (-1.35% surprise). After-hours trading saw the stock drop 1.34% to $12.51.

The company showed strong financial discipline, with net income up over 70% year-over-year. Gross profit margin hit nearly 60%, and return on equity was 18%. The focus on on-campus undergraduate programs, especially medical schools, now accounts for 81% of total revenue, shifting away from lower-margin distance learning.

Despite the earnings beat, the stock fell 1.34% after-hours to $12.51. The current price of $11.90 reflects a 4.88% decline since the report. Bond.az analysis suggests the stock is undervalued with a P/E ratio of just 6.62. The company has a financial health score of 3.34/5 and a Piotroski Score of 8.

Ser Educacional continues to focus on operational efficiency. It plans to open five new units in 2026, mainly expansions of existing ones. Medical school expansion remains a priority, with injunctions progressing throughout the year.

More News
Today / 16:40
|
575

Rubicon Organics Q1 2026 Earnings Miss, Stock Falls

Rubicon Organics Q1 2026 earnings miss: EPS of -0.04 CAD, revenue of 13.69 million CAD, stock down 11%. Company expects improvement in H2 2026.

0
Today / 14:40
|
851

Vallourec Q1 2026 Beats Forecasts, Stock Fluctuates

Vallourec Q1 2026 earnings beat forecasts; stock sees volatility. Strong EBITDA and cash flow highlight performance.

0
Today / 14:20
|
888

Home Depot Q1 2026 earnings beat forecasts, stock dips

Home Depot Q1 2026 earnings beat forecasts with EPS of $3.43 and revenue of $41.8B. Stock dips 2.49% amid margin concerns.

0
Today / 14:03
|
352

Hera Group Q1 2026: Steady growth

Hera Group posts steady growth in Q1 2026 with net profit of EUR 155 million and EPS of $0.105.

0
Today / 14:02
|
259

Oxford Lane Capital NAV drops, stock dips

Oxford Lane Capital Corp reports Q4 FY2026 results: NAV per share down, stock falls 4.03%. CLO yields decline. Read more on challenges and outlook.

0
Today / 13:43
|
246

Driven Brands Q4 2025 Revenue Growth Reported

Driven Brands Q4 2025 revenue grows 7.7% to $460.1M, EPS $0.34. Stock up 1.12%.

0
Today / 13:41
|
777

Ceragon Q1 2026 Revenue Beats Estimates

Ceragon Networks Q1 2026 revenue beat estimates at $85M. EPS $0.01. Stock rose 6.77% premarket. Full-year guidance reiterated.

0
Today / 13:10
|
740

Fractyl Health Q1 2026 EPS Beat, Shares Surge 23%

Fractyl Health Q1 2026 EPS beat expectations by 76%, shares surged 23% after hours. Revita program data expected in Q4 2026.

0
Today / 13:01
|
272

Antalpha Q1 2026: EPS Misses Forecast, Stock Rises

Antalpha Q1 2026: EPS misses forecast at $0.07, stock rises 2.42%. Revenue up 52% to $20.7M. Web3 AI agent Nina launched. Q2 guidance $11M-$13M.

0
Today / 12:44
|
314

GNFC Q4 profit surges, stock climbs 5.17%

GNFC Q4 FY2026 strong results: revenue up 11%, PAT up 35%, stock rises 5.17%. Chemical segment drives growth.

0
Today / 12:42
|
677

Relmada TX Q1 2026: Loss and stock dip

Relmada Therapeutics Q1 2026 results: stock declines, strong cash position and NDV-01 program in focus.

0
Today / 12:00
|
959

Inovio Beats Q1 2026 EPS Forecast, Stock Slips

Inovio Q1 2026 EPS beats forecasts, but stock falls. Detailed financial analysis and outlook on Bond.az.

0
...